PAI-1
PAI-1(纤溶酶原激活物抑制物1)
Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA), and functionally serves to suppress tissue and plasma fibrinolysis.
PAI-1 is a member of the serpin family of proteins and exists in multiple conformations of which a minor component, the “active” form, exhibits inhibitory effects against tPA and uPA.
PAI-1 is an endogenous inhibitor of urokinase-type plasminogen activator (uPA), and its expression is regulated by a number of intrinsic factors (e.g., cytokines and growth factors) and extrinsic factors (e.g., cellular stress).
PAI-1 seems to play a pivotal role in tumor growth and may represent a potential therapeutic target for bladder cancer.
PAI-1 相关产品(13)
- GC12387Tiplaxtinin(PAI-039)CAS: 393105-53-8纯度: >98.00%
Tiplaxtinin(PAI-039)是一种口服生物利用的尿激酶型纤溶酶原激活物抑制剂-1(PAI-1)拮抗剂,IC 50 值为2.7μM。
- GC34324ZK824859 hydrochloride纯度: >99.00%
ZK824859hydrochloride是一种口服有效的选择性尿激酶型纤溶酶原激活剂(uPA)抑制剂,用于人uPA,tPA和纤溶酶,IC50分别为79nM,1580nM和1330nM。
- GC38971ToddalolactoneCAS: 483-90-9纯度: >98.00%
Toddalolactone, a natural coumarin, inhibits the activity of recombinant human Plasminogen activator inhibitor-1 (PAI-1) in a dose-dependent manner, yielding an IC50 value of 37.31 ± 3.23 μM.
- GC65281AleplasininCAS: 481629-87-2纯度: >99.00%
Aleplasinin 是一种口服有效的、可透过血脑屏障的、选择性的 SERPINE1 (PAI-1,纤溶酶原激活物抑制剂 -1) 抑制剂。Aleplasinin 增加淀粉样蛋白 -β (Aβ) 分解代谢,改善淀粉样蛋白相关病理。Aleplasinin 可改善记忆缺陷。Aleplasinin 可用于阿尔茨海默病的研究。
- GC67781DiaplasininCAS: 481631-45-2纯度: >99.00%
Diaplasinin (PAI-749) 是纤溶酶原激活剂抑制剂-1 (PAI-1) 抑制剂,IC50 为 295 nm。具有抗血栓功效。
- GC72878UCD38B hydrochlorideCAS: 1115177-19-9纯度: >99.00%
UCD38B hydrochloride是一种细胞渗透的竞争性酶促uPA抑制剂,IC50值为7 μM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12387 | Tiplaxtinin(PAI-039) | 393105-53-8 | >98.00% | |
Tiplaxtinin(PAI-039)是一种口服生物利用的尿激酶型纤溶酶原激活物抑制剂-1(PAI-1)拮抗剂,IC 50 值为2.7μM。 | ||||
| GC18173 | TM5441 | 1190221-43-2 | >98.00% | |
TM5441是一种具有口服生物利用度的纤溶酶原激活物抑制剂-1(PAI-1)抑制剂,其IC₅₀值介于13.9至51.1μM之间,并能在多种人类癌细胞系中诱导内源性凋亡。 | ||||
| GC19358 | TM5275 sodium | 1103926-82-4 | >98.00% | |
A PAI-1 inhibitor | ||||
| GC31889 | ZK824859 | 2271122-53-1 | - | |
ZK824859 is a potent, selective and orally bioavailable inhibitor of urokinase plasminogen activator (uPA) with IC50 of 79?nM, 1580?nM and 1330?nM for human uPA, tPA, and plasmin, respectively. | ||||
| GC34324 | ZK824859 hydrochloride | - | >99.00% | |
ZK824859hydrochloride是一种口服有效的选择性尿激酶型纤溶酶原激活剂(uPA)抑制剂,用于人uPA,tPA和纤溶酶,IC50分别为79nM,1580nM和1330nM。 | ||||
| GC38971 | Toddalolactone | 483-90-9 | >98.00% | |
Toddalolactone, a natural coumarin, inhibits the activity of recombinant human Plasminogen activator inhibitor-1 (PAI-1) in a dose-dependent manner, yielding an IC50 value of 37.31 ± 3.23 μM. | ||||
| GC61511 | Angstrom6 | 220334-14-5 | >99.00% | |
Angstrom6(A6Peptide)是一种来源于单链尿激酶纤溶酶原激活剂(scuPA)的8个氨基酸的肽,可干扰uPA/uPAR级联反应并消除下游效应。Angstrom6与CD44结合,抑制肿瘤细胞的迁移、侵袭和转移,调节CD44介导的细胞信号。 | ||||
| GC65281 | Aleplasinin | 481629-87-2 | >99.00% | |
Aleplasinin 是一种口服有效的、可透过血脑屏障的、选择性的 SERPINE1 (PAI-1,纤溶酶原激活物抑制剂 -1) 抑制剂。Aleplasinin 增加淀粉样蛋白 -β (Aβ) 分解代谢,改善淀粉样蛋白相关病理。Aleplasinin 可改善记忆缺陷。Aleplasinin 可用于阿尔茨海默病的研究。 | ||||
| GC67781 | Diaplasinin | 481631-45-2 | >99.00% | |
Diaplasinin (PAI-749) 是纤溶酶原激活剂抑制剂-1 (PAI-1) 抑制剂,IC50 为 295 nm。具有抗血栓功效。 | ||||
| GC68013 | CDE-096 | 1228357-04-7 | - | |
CDE-096 是一种有效的 PAI-1 抑制剂。CDE-096 可防止PAI-1 以类似的效力 (分别为 IC50=30 和25 nM) 使 tPA 和 uPA 失活,并对糖基化 PAI-1 以及来源于几种物种的 PAI-1 具有活性 (对小鼠、大鼠和猪 PAI-1 分别为 IC50=19、22 和 18 nM)。 | ||||
| GC70534 | PPACK TFA | 157379-44-7 | >99.00% | |
PPACK TFA是一种纤溶酶原激活剂(rt-PA)抑制剂。 | ||||
| GC72878 | UCD38B hydrochloride | 1115177-19-9 | >99.00% | |
UCD38B hydrochloride是一种细胞渗透的竞争性酶促uPA抑制剂,IC50值为7 μM。 | ||||
| GN10267 | Loureirin B | 119425-90-0 | >99.00% | |
A flavonoid with diverse biological activities | ||||
